Dr. Michael Diringer joined Washington University in 1992 as the founding director of the Neurology/Neurosurgery Intensive Care Unit and head of the Neurological Critical Care Section. He developed a multidisciplinary team that provides comprehensive critical care services for neurology and neurosurgery patients which is regarded as one of the leading critical care programs in the country.
An internationally recognized leader in the field of Neurocritical Care, Dr. Diringer has focused his NIH funded research on the physiological responses to therapeutic interventions applied to critically ill neuro patients. Using quantitative PET and advanced MRI techniques, his group has made fundamental observations that set the stage for changes in clinical practice with regard to blood pressure management in intracerebral hemorrhage, hyperventilation in traumatic brain injury, the brain’s response to osmotic therapy and medical management of delayed cerebral ischemia following subarachnoid hemorrhage. Dr. Diringer also has extensive experience executing clinical trials for intracerebral hemorrhage and subarachnoid hemorrhage serving on the steering and data and safety monitoring committees for trials in subarachnoid hemorrhage, traumatic brain injury and ischemic stroke.
Dr. Diringer earned his Bachelors in Psychology from SUNY at Stony Brook University, his master’s in Neuropsychopharmacology from the University of Louisville and his MD from the University of Kentucky. Dr. Diringer served as the second President of the Neurocritical Care Society and will soon take over the role of Editor-in-Chief for the journal Neurocritical Care.